Its innovative mechanism of action acts on keratinocytes4 (fig. 1), inhibiting the release of melanocyte stimulating agents and factors triggering the inflammatory and vascular process: prostaglandins (PG)5-8 and endothelin-1 (ET-1)9-11.
tran3x is an innovative, modular program that combines several treatment categories for a flexible, integral depigmentation action that allows to act on hyperpigmentation at several depths. Minimally invasive.
It allows combining different methods to modulate depigmenting intensity.